Prosecution Insights
Last updated: October 02, 2026

Examiner: WRUBLESKI, MATTHEW JAMES

Tech Center 3700 • Art Units: 3781 3783

This examiner grants 59% of resolved cases

Analysis

Matthew James Wrubleski handles cases in Tech Center 3700 and Art Unit 3781, with 114 resolved cases to date. His allowance rate of 58.8 percent suggests the examination process. Applicants should also account for a median days to allowance of 1112 when planning their prosecution strategy. This timeframe indicates that reaching a resolution in Art Unit 3781 requires a time investment.

An aspect of his profile is the 60.4 percent interview lift. This figure indicates that an interview is a step that increases the 58.8 percent baseline allowance rate. For the 114 cases resolved, engaging in direct dialogue is a way to improve outcomes and manage the 1112-day median timeline. Practitioners may use interviews as a component of their advocacy in Tech Center 3700. The 60.4 percent lift is a key metric for this examiner.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

58.8%
Allow Rate
-11.2% vs TC avg
157
Total Applications
+60.4%
Interview Lift
1112
Avg Prosecution Days
Based on 114 resolved cases, 2023–2026

Rejection Statute Breakdown

1.3%
§101 Eligibility
18.2%
§102 Novelty
58.1%
§103 Obviousness
15.2%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18976779 ABSORBENT ARTICLE Non-Final OA The Procter & Gamble Company
18696653 WOUND DRESSING APPARATUSES AND METHODS FOR NITRIC OXIDE DELIVERY Non-Final OA T.J.Smith and Nephew,Limited
18704670 ATRAUMATIC CATHETER Final Rejection THE GENERAL HOSPITAL CORPORATION
18380298 PRESSURE OUTPUT DEVICES FOR SENSING FLUID PRESSURE IN A FLUID PROCESSING SYSTEM Final Rejection Fresenius Medical Care Holdings, Inc.
18568646 Drainage System Including Actuation Device For Providing A Negative Pressure For Draining And Collecting Bodily Fluids Non-Final OA Becton Dickinson and Company
18566362 DRUG-ELUTING TUBES FOR IMPROVED PATIENT CARE Final Rejection BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
18609490 BLOOD CIRCULATION SYSTEM Final Rejection TERUMO KABUSHIKI KAISHA
18683966 ABSORBENT ARTICLE Non-Final OA Essity Hygiene and Health Aktiebolag
17771126 URINARY CATHETERS AND METHODS FOR PREVENTING BACTERIAL INFECTIONS Non-Final OA Hollister Incorporated
19048004 FLUID COLLECTION ASSEMBLIES INCLUDING AT LEAST ONE INFLATION DEVICE AND METHODS AND SYSTEMS OF USING THE SAME Non-Final OA PUREWICK CORPORATION
19038774 FLUID COLLECTION ASSEMBLIES INCLUDING AT LEAST ONE LENGTH ADJUSTING FEATURE Non-Final OA PUREWICK CORPORATION
18569778 URINE COLLECTION SYSTEMS HAVING A CLEANING SYSTEM, AND RELATED METHODS Non-Final OA PUREWICK CORPORATION
18549387 FLUID COLLECTION DEVICE Final Rejection PUREWICK CORPORATION
18254638 FLUID COLLECTION DEVICES WITH ANATOMICAL FIT Final Rejection PUREWICK CORPORATION
18150360 FLUID COLLECTION DEVICES INCLUDING A DRY ADHESIVE REGION, AND RELATED SYSTEMS AND METHODS Non-Final OA PUREWICK CORPORATION
18968935 DIVERTER FOR MEMBRANE OXYGENATION DEVICE Non-Final OA Lifemotion Medical Technology Co., Ltd.
18706470 NEGATIVE PRESSURE WOUND THERAPY DRESSING WITH ISOLATED SUPER ABSORBENT Non-Final OA KCI Manufacturing Unlimited Company
18035902 EXTENDED WEAR DRESSING WITH SLOUGH CLEANING HOLES Non-Final OA KCI Manufacturing Unlimited Company
17016952 APPARATUSES AND METHODS FOR IMPROVING RECOVERY FROM MINIMALLY INVASIVE SURGERY Final Rejection Noleus Technologies, Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month